These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

713 related articles for article (PubMed ID: 32224049)

  • 1. Obstructive sleep apnoea and cardiovascular consequences: Pathophysiological mechanisms.
    Arnaud C; Bochaton T; Pépin JL; Belaidi E
    Arch Cardiovasc Dis; 2020 May; 113(5):350-358. PubMed ID: 32224049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardiovascular morbidity associated with obstructive sleep apnea syndrome].
    Destors M; Tamisier R; Baguet JP; Levy P; Pepin JL
    Rev Mal Respir; 2014 Apr; 31(4):375-85. PubMed ID: 24750957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular responses to hypoxia are not impaired in obstructive sleep apnoea patients free of overt cardiovascular disease.
    Beaudin AE; Hanly PJ; Raneri JK; Sajobi TT; Anderson TJ; Poulin MJ
    Exp Physiol; 2019 Apr; 104(4):580-600. PubMed ID: 30697840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on cardiovascular effects of obstructive sleep apnoea syndrome.
    Uyar M; Davutoglu V
    Postgrad Med J; 2016 Sep; 92(1091):540-4. PubMed ID: 27317753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obstructive sleep apnoea and cardiovascular complications: perception versus knowledge.
    Thomas JJ; Ren J
    Clin Exp Pharmacol Physiol; 2012 Dec; 39(12):995-1003. PubMed ID: 23082844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation.
    Garvey JF; Taylor CT; McNicholas WT
    Eur Respir J; 2009 May; 33(5):1195-205. PubMed ID: 19407053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sleep apnoea and the heart.
    Lévy P; Ryan S; Oldenburg O; Parati G
    Eur Respir Rev; 2013 Sep; 22(129):333-52. PubMed ID: 23997061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent hypoxia in obese Zucker rats: cardiometabolic and inflammatory effects.
    Briançon-Marjollet A; Monneret D; Henri M; Joyeux-Faure M; Totoson P; Cachot S; Faure P; Godin-Ribuot D
    Exp Physiol; 2016 Nov; 101(11):1432-1442. PubMed ID: 27615447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of losartan and allopurinol on cardiorespiratory regulation in obstructive sleep apnoea.
    Morgan BJ; Teodorescu M; Pegelow DF; Jackson ER; Schneider DL; Plante DT; Gapinski JP; Hetzel SJ; Dopp JM
    Exp Physiol; 2018 Jul; 103(7):941-955. PubMed ID: 29750475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the ROS-HIF-1-endothelin axis as a therapeutic approach for the treatment of obstructive sleep apnea-related cardiovascular complications.
    Belaidi E; Morand J; Gras E; Pépin JL; Godin-Ribuot D
    Pharmacol Ther; 2016 Dec; 168():1-11. PubMed ID: 27492897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sleep apnea syndromes and cardiovascular disease].
    Bounhoure JP; Galinier M; Didier A; Leophonte P
    Bull Acad Natl Med; 2005 Mar; 189(3):445-59; discussion 460-4. PubMed ID: 16149210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obstructive sleep apnoea syndrome.
    Lévy P; Kohler M; McNicholas WT; Barbé F; McEvoy RD; Somers VK; Lavie L; Pépin JL
    Nat Rev Dis Primers; 2015 Jun; 1():15015. PubMed ID: 27188535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obstructive sleep apnea: the new cardiovascular disease. Part I: Obstructive sleep apnea and the pathogenesis of vascular disease.
    Khayat R; Patt B; Hayes D
    Heart Fail Rev; 2009 Sep; 14(3):143-53. PubMed ID: 18807180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanisms of cardiovascular damage in obstructive sleep apnea].
    Torre-Bouscoulet L; Castorena-Maldonado A; Sada-Ovalle I; Meza-Vargas MS
    Rev Invest Clin; 2008; 60(6):502-16. PubMed ID: 19378837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carotid body potentiation induced by intermittent hypoxia: implications for cardiorespiratory changes induced by sleep apnoea.
    Iturriaga R; Moya EA; Del Rio R
    Clin Exp Pharmacol Physiol; 2009 Dec; 36(12):1197-204. PubMed ID: 19473190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent hypoxia and vascular function: implications for obstructive sleep apnoea.
    Foster GE; Poulin MJ; Hanly PJ
    Exp Physiol; 2007 Jan; 92(1):51-65. PubMed ID: 17124276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obstructive sleep apnea syndrome and cardiovascular diseases.
    Fava C; Montagnana M; Favaloro EJ; Guidi GC; Lippi G
    Semin Thromb Hemost; 2011 Apr; 37(3):280-97. PubMed ID: 21455862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obstructive sleep apnea and cardiovascular disease: a perspective and future directions.
    Pack AI; Gislason T
    Prog Cardiovasc Dis; 2009; 51(5):434-51. PubMed ID: 19249449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obstructive sleep apnea, stroke, and cardiovascular diseases.
    Bagai K
    Neurologist; 2010 Nov; 16(6):329-39. PubMed ID: 21150380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OSA and cardiometabolic risk: What's the bottom line?
    Hoyos CM; Drager LF; Patel SR
    Respirology; 2017 Apr; 22(3):420-429. PubMed ID: 28161892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.